A-kinase anchor protein 9 (1398-1407)

A-kinase anchor protein 9 (1398-1407) is a synthetic peptide segment derived from the C-terminal region of the A-kinase anchor protein 9 (AKAP9). As a member of the AKAP family, AKAP9 plays a pivotal role in the spatial and temporal regulation of protein kinase A (PKA) signaling within cells, mediating the localization of PKA to specific subcellular compartments. The 1398-1407 fragment corresponds to a region implicated in protein-protein interactions and anchoring functions, making it a valuable tool for researchers studying kinase signaling, scaffolding mechanisms, and the modulation of cellular signaling complexes. Its defined sequence and biochemical properties enable precise investigation of AKAP9-related processes in vitro and in cell-based systems.

Signal transduction research: The peptide fragment corresponding to residues 1398-1407 of AKAP9 is frequently utilized to probe the molecular mechanisms governing PKA anchoring and compartmentalization. By serving as a competitive inhibitor or molecular decoy, it allows researchers to dissect the contribution of specific AKAP9 domains to the assembly and localization of PKA signaling complexes. This facilitates detailed studies on how spatial organization of kinase activity influences downstream phosphorylation events and cellular responses, providing insight into fundamental mechanisms of intracellular signaling.

Protein-protein interaction mapping: In biochemical and structural biology laboratories, the AKAP9 (1398-1407) peptide is employed as a tool to identify and characterize binding partners of the AKAP9 C-terminal region. Its use in pull-down assays, affinity chromatography, or surface plasmon resonance experiments enables the elucidation of interaction motifs and interfaces critical for scaffold assembly. Such studies help clarify how AKAP9 orchestrates multiprotein complexes and mediates cross-talk between kinase pathways, supporting the development of targeted modulators of protein-protein interactions.

Peptide-based inhibitor development: The defined sequence of this AKAP9-derived peptide provides a template for the rational design and screening of peptide-based inhibitors that modulate AKAP-PKA interactions. Researchers utilize the 1398-1407 fragment to assess binding affinities, specificity, and inhibitory potential of candidate molecules in vitro, supporting early-stage discovery of chemical probes for dissecting kinase anchoring mechanisms. These efforts contribute to the broader field of signal transduction research, where selective disruption of protein scaffolds can reveal novel regulatory nodes.

Cellular localization studies: Fluorescently labeled or tagged versions of the AKAP9 (1398-1407) peptide can be introduced into cultured cells to monitor the intracellular distribution and targeting of AKAP9 domains. Such applications are instrumental in visualizing the dynamics of scaffold recruitment, mapping subcellular microdomains of kinase activity, and understanding how perturbation of anchoring motifs affects cellular architecture. This approach is particularly valuable for live-cell imaging and quantitative microscopy studies investigating the spatial regulation of signaling networks.

Structural and biophysical analysis: The AKAP9 (1398-1407) peptide serves as a model system for high-resolution structural studies, including NMR spectroscopy and X-ray crystallography, aimed at elucidating the conformational features of the AKAP9 C-terminal region. Its defined length and sequence facilitate detailed analysis of secondary structure, folding dynamics, and interaction surfaces. Such structural insights are crucial for understanding the molecular basis of AKAP-mediated scaffolding and for guiding the design of synthetic analogs with altered binding properties.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

3. Emu oil in combination with other active ingredients for treating skin imperfections

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats